logo

Immunogen Inc (IMGN)



Trade IMGN now with
  Date
  Headline
6/6/2018 9:04:59 PM ImmunoGen Announces Pricing Of An Upsized Underwritten Public Offering Of 13.70 Mln Shares At $11.00/shr
6/5/2018 4:04:39 PM ImmunoGen Announces Proposed Public Offering Of Common Stock
5/4/2018 6:35:37 AM ImmunoGen Q1 Net Loss $38.6 Mln Or $0.30/Shr Vs Net Loss $17.3 Mln Or $0.20/Shr Last Year
4/25/2018 8:04:47 AM ImmunoGen Names Blaine McKee EVP And Chief Business Officer
2/9/2018 6:32:32 AM ImmunoGen FY Revenues $115.4 Mln Vs $48.6 Mln Last Year
1/24/2018 8:09:59 AM ImmunoGen Appoints Stuart Arbuckle To Board
11/3/2017 6:41:30 AM ImmunoGen Q3 Net Loss $56.7 Mln Or $0.61/Shr Vs Loss Of $44.7 Mln Or $0.51/Shr Last Year
11/3/2017 4:45:45 AM In The Spotlight: ImmunoGen
10/16/2017 8:09:46 AM ImmunoGen Announces IND Application For IMGN632 For Hematological Malignancies Is Active
10/11/2017 4:16:54 PM ImmunoGen Announces Closing Of Public Offering Of Common Stock
10/4/2017 4:02:00 PM ImmunoGen Announces Proposed Public Offering Of Common Stock